US2020390758A1PendingUtilityA1

Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof

Assignee: INSMED INCPriority: Dec 8, 2005Filed: Jan 17, 2020Published: Dec 17, 2020
Est. expiryDec 8, 2025(expired)· nominal 20-yr term from priority
Inventors:Jeff Weers
A61M 11/001A61K 9/0073A61K 9/14A61P 31/10A61K 47/26A61P 11/08A61M 11/005A61K 45/06A61K 9/127A61K 31/7048A61K 31/496A61P 31/12A61K 9/0078A61K 9/008A61M 11/02A61M 11/006A61M 15/08A61P 11/00A61K 31/7034A61K 31/7036A61M 15/0091A61P 31/04A61P 31/08A61P 31/06A61M 15/009A61P 31/00Y02A50/30
73
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A system for treating or providing prophylaxus against a pulmonary infection is disclosed comprising: a) a pharmaceutical formulation comprising a mixture of free antiinfective and antiinfective encapsulated in a lipid-based composition, and b) an inhalation delivery device. A method for providing prophylaxis against a pulmonary infection in a patient and a method of reducing the loss of antiinfective encapsulated in a lipid-based composition upon nebulization comprising administering an aerosolized pharmaceutical formulation comprising a mixture of free antiinfective and antiinfective encapsulated in a lipid-based composition is also disclosed.

Claims

exact text as granted — not AI-modified
1 . A system for treating or providing prophylaxis against a pulmonary infection comprising:
 a) a pharmaceutical formulation comprising a mixture of free antiinfective and antiinfective encapsulated in a lipid-based composition, wherein the amount of free antiinfective is sufficient to provide for immediate bactericidal activity, and the amount of encapsulated antiinfective is sufficient to provide sustained bactericidal activity and reduce the development of resistant strains of the infective agent, and   b) an inhalation delivery device.   
     
     
         2 .- 45 . (canceled)

Join the waitlist — get patent alerts

Track US2020390758A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.